Ozempic alternatives for type 2 diabetes As of 2026, six other GLP-1 medications are approved for the treatment of type 2 diabetes: Rybelsus (semaglutide), Mounjaro (tirzepatide), Trulicity (dulaglutide), Victoza (liraglutide), Bydureon BCise (exenatide) and Byetta (exenatide)
Support your weight loss with clinically proven medication Fat Mass Increased amount of Fat mass reduction vs placebo In a double-blind controlled clinical trial, patients lost more that 2x the amount of fat mass when compared with a placebo
Lilly is expected to file a new drug application in 2026, with approval most likely in 2027 or 2028
If you only address appetite, you may lose weight, but it can be harder to maintain
Create an account Already got an account